rigel Search Results


cd20  (Novus Biologicals)
93
Novus Biologicals cd20
Cd20, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd20/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
cd20 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
rigel 773 novus biologicals  (Novus Biologicals)
93
Novus Biologicals rigel 773 novus biologicals
Rigel 773 Novus Biologicals, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rigel 773 novus biologicals/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
rigel 773 novus biologicals - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
syk inhibitor  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals syk inhibitor
Syk Inhibitor, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/syk inhibitor/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
syk inhibitor - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
syk inhibitor fostamatinib  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals syk inhibitor fostamatinib
Syk Inhibitor Fostamatinib, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/syk inhibitor fostamatinib/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
syk inhibitor fostamatinib - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
syk inhibitor fostamatinib r788  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals syk inhibitor fostamatinib r788
Syk Inhibitor Fostamatinib R788, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/syk inhibitor fostamatinib r788/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
syk inhibitor fostamatinib r788 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
r763  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals r763
R763, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/r763/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
r763 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
mechanical ventilation of rats  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals mechanical ventilation of rats
Mechanical Ventilation Of Rats, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mechanical ventilation of rats/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
mechanical ventilation of rats - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
inhibitors r406  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals inhibitors r406
Effect of Syk inhibitor on IgG-stimulated production of MCP-1 from WKY rat mesangial cells and macrophages is shown. (A) There was a dose-dependent reduction of MCP-1 by incubation of mesangial cells with <t>R406:</t> 386 pg/ml (365 to 399 pg/ml) in medium only versus 200 pg/ml (186 to 210 pg/ml) after incubation with 1 μM R406 (P < 0.005, Kruskal-Wallis test). The results are representative of three experiments. (B) There was a dose-dependent reduction of MCP-1 by incubation of bone marrow–derived macrophages with R406: 1295 ng/ml (1152 to 1836 ng/ml) in medium only versus 25 ng/ml (19 to 29 ng/ml) after incubation with 2 μM R406 (P < 0.0005).
Inhibitors R406, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inhibitors r406/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
inhibitors r406 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
balloon catheter rigel balloon dilatation catheter  (Japan Lifeline Co Ltd)
90
Japan Lifeline Co Ltd balloon catheter rigel balloon dilatation catheter
Effect of Syk inhibitor on IgG-stimulated production of MCP-1 from WKY rat mesangial cells and macrophages is shown. (A) There was a dose-dependent reduction of MCP-1 by incubation of mesangial cells with <t>R406:</t> 386 pg/ml (365 to 399 pg/ml) in medium only versus 200 pg/ml (186 to 210 pg/ml) after incubation with 1 μM R406 (P < 0.005, Kruskal-Wallis test). The results are representative of three experiments. (B) There was a dose-dependent reduction of MCP-1 by incubation of bone marrow–derived macrophages with R406: 1295 ng/ml (1152 to 1836 ng/ml) in medium only versus 25 ng/ml (19 to 29 ng/ml) after incubation with 2 μM R406 (P < 0.0005).
Balloon Catheter Rigel Balloon Dilatation Catheter, supplied by Japan Lifeline Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/balloon catheter rigel balloon dilatation catheter/product/Japan Lifeline Co Ltd
Average 90 stars, based on 1 article reviews
balloon catheter rigel balloon dilatation catheter - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
apramycin  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals apramycin
Effect of Syk inhibitor on IgG-stimulated production of MCP-1 from WKY rat mesangial cells and macrophages is shown. (A) There was a dose-dependent reduction of MCP-1 by incubation of mesangial cells with <t>R406:</t> 386 pg/ml (365 to 399 pg/ml) in medium only versus 200 pg/ml (186 to 210 pg/ml) after incubation with 1 μM R406 (P < 0.005, Kruskal-Wallis test). The results are representative of three experiments. (B) There was a dose-dependent reduction of MCP-1 by incubation of bone marrow–derived macrophages with R406: 1295 ng/ml (1152 to 1836 ng/ml) in medium only versus 25 ng/ml (19 to 29 ng/ml) after incubation with 2 μM R406 (P < 0.0005).
Apramycin, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apramycin/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
apramycin - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
tavalisse  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals tavalisse
Effect of Syk inhibitor on IgG-stimulated production of MCP-1 from WKY rat mesangial cells and macrophages is shown. (A) There was a dose-dependent reduction of MCP-1 by incubation of mesangial cells with <t>R406:</t> 386 pg/ml (365 to 399 pg/ml) in medium only versus 200 pg/ml (186 to 210 pg/ml) after incubation with 1 μM R406 (P < 0.005, Kruskal-Wallis test). The results are representative of three experiments. (B) There was a dose-dependent reduction of MCP-1 by incubation of bone marrow–derived macrophages with R406: 1295 ng/ml (1152 to 1836 ng/ml) in medium only versus 25 ng/ml (19 to 29 ng/ml) after incubation with 2 μM R406 (P < 0.0005).
Tavalisse, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tavalisse/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
tavalisse - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
r112  (Rigel Pharmaceuticals)
90
Rigel Pharmaceuticals r112
Effect of Syk inhibitor on IgG-stimulated production of MCP-1 from WKY rat mesangial cells and macrophages is shown. (A) There was a dose-dependent reduction of MCP-1 by incubation of mesangial cells with <t>R406:</t> 386 pg/ml (365 to 399 pg/ml) in medium only versus 200 pg/ml (186 to 210 pg/ml) after incubation with 1 μM R406 (P < 0.005, Kruskal-Wallis test). The results are representative of three experiments. (B) There was a dose-dependent reduction of MCP-1 by incubation of bone marrow–derived macrophages with R406: 1295 ng/ml (1152 to 1836 ng/ml) in medium only versus 25 ng/ml (19 to 29 ng/ml) after incubation with 2 μM R406 (P < 0.0005).
R112, supplied by Rigel Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/r112/product/Rigel Pharmaceuticals
Average 90 stars, based on 1 article reviews
r112 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Effect of Syk inhibitor on IgG-stimulated production of MCP-1 from WKY rat mesangial cells and macrophages is shown. (A) There was a dose-dependent reduction of MCP-1 by incubation of mesangial cells with R406: 386 pg/ml (365 to 399 pg/ml) in medium only versus 200 pg/ml (186 to 210 pg/ml) after incubation with 1 μM R406 (P < 0.005, Kruskal-Wallis test). The results are representative of three experiments. (B) There was a dose-dependent reduction of MCP-1 by incubation of bone marrow–derived macrophages with R406: 1295 ng/ml (1152 to 1836 ng/ml) in medium only versus 25 ng/ml (19 to 29 ng/ml) after incubation with 2 μM R406 (P < 0.0005).

Journal: Journal of the American Society of Nephrology : JASN

Article Title: A Spleen Tyrosine Kinase Inhibitor Reduces the Severity of Established Glomerulonephritis

doi: 10.1681/ASN.2009030263

Figure Lengend Snippet: Effect of Syk inhibitor on IgG-stimulated production of MCP-1 from WKY rat mesangial cells and macrophages is shown. (A) There was a dose-dependent reduction of MCP-1 by incubation of mesangial cells with R406: 386 pg/ml (365 to 399 pg/ml) in medium only versus 200 pg/ml (186 to 210 pg/ml) after incubation with 1 μM R406 (P < 0.005, Kruskal-Wallis test). The results are representative of three experiments. (B) There was a dose-dependent reduction of MCP-1 by incubation of bone marrow–derived macrophages with R406: 1295 ng/ml (1152 to 1836 ng/ml) in medium only versus 25 ng/ml (19 to 29 ng/ml) after incubation with 2 μM R406 (P < 0.0005).

Article Snippet: The inhibitors R406 and R788 were provided by Rigel Pharmaceuticals (San Francisco, CA).

Techniques: Incubation, Derivative Assay